AlphaFold predicted structure
NDUFA6 · P56556

Mean pLDDT
87.5/ 100
Confident
128 residues
Confidence breakdown
- Very high(≥ 90)66%
- Confident(70–90)22%
- Low(50–70)6%
- Very low(< 50)6%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
NADH:ubiquinone oxidoreductase subunit A6
Annotations refreshed 10 hours ago.
Diagnostic Grade (Green)
DDG2P
BIALLELIC, autosomal or pseudoautosomalFetal anomalies
BIALLELIC, autosomal or pseudoautosomalLikely inborn error of metabolism
BIALLELIC, autosomal or pseudoautosomalMitochondrial disorder with complex I deficiency
BIALLELIC, autosomal or pseudoautosomalMitochondrial disorders
BIALLELIC, autosomal or pseudoautosomalPossible mitochondrial disorder - nuclear genes
BIALLELIC, autosomal or pseudoautosomalPaediatric or syndromic cardiomyopathy
BIALLELIC, autosomal or pseudoautosomalmitochondrial complex I deficiency, nuclear type 33
type 2 diabetes mellitus
mitochondrial complex I deficiency
diabetes mellitus
neurodegenerative disease
mitochondrial disease
Parkinson disease
multiple sclerosis
Alzheimer disease
lysosomal storage disease
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6
Accessory subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I), that is believed to be not involved in catalysis. Required for proper complex I assembly (PubMed:30245030). Complex I functions in the transfer of electrons from NADH to the respiratory chain. The immediate electron acceptor for the enzyme is believed to be ubiquinone
NDUFA6 · P56556

Mean pLDDT
87.5/ 100
Confident
128 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0